• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克拉霉素诱发尖端扭转型室性心动过速。

Clarithromycin induced torsade de pointes.

作者信息

Hensey C, Keane D

机构信息

Department of Cardiology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

出版信息

Ir J Med Sci. 2008 Mar;177(1):67-8. doi: 10.1007/s11845-007-0057-3. Epub 2007 Jul 7.

DOI:10.1007/s11845-007-0057-3
PMID:17618400
Abstract

BACKGROUND

Clarithromycin is a commonly used macrolide antibiotic. It is known to cause QT prolongation. Medication induced QT prolongation is a major risk factor for the development of torsade de pointes.

METHODS

A 79-year-old lady presented with frequent episodes of torsade de pointes following commencement of clarithromycin. This was noted to be in association with a prolongation of the QT interval.

CONCLUSION

Knowledge of medications which prolong the QT interval is important to minimize the risk of ventricular arrhythmias, which may lead to sudden death. This is essential in patients with a congenitally long QT interval.

摘要

背景

克拉霉素是一种常用的大环内酯类抗生素。已知其会导致QT间期延长。药物诱导的QT间期延长是尖端扭转型室速发生的主要危险因素。

方法

一名79岁女性在开始使用克拉霉素后出现频繁的尖端扭转型室速发作。发现这与QT间期延长有关。

结论

了解可延长QT间期的药物对于将可能导致猝死的室性心律失常风险降至最低很重要。这对于先天性QT间期延长的患者至关重要。

相似文献

1
Clarithromycin induced torsade de pointes.克拉霉素诱发尖端扭转型室性心动过速。
Ir J Med Sci. 2008 Mar;177(1):67-8. doi: 10.1007/s11845-007-0057-3. Epub 2007 Jul 7.
2
Clarithromycin-Induced Torsades de Pointes.
Am J Ther. 2016 May-Jun;23(3):e955-6. doi: 10.1097/MJT.0000000000000109.
3
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].[米安色林治疗期间的QT间期延长和尖端扭转型室性心动过速。鉴别诊断和治疗方面]
Dtsch Med Wochenschr. 2001 Dec 7;126(49):1396-400. doi: 10.1055/s-2001-18880.
4
Torsades de pointes due to drug interaction between disopyramide and clarithromycin.丙吡胺与克拉霉素药物相互作用导致尖端扭转型室速。
Heart Dis. 1999 Sep-Oct;1(4):206-7.
5
Azithromycin-induced torsade de pointes.阿奇霉素诱发的尖端扭转型室性心动过速。
Pacing Clin Electrophysiol. 2007 Dec;30(12):1579-82. doi: 10.1111/j.1540-8159.2007.00912.x.
6
Torsade de pointes induced by cisapride/clarithromycin interaction.西沙必利/克拉霉素相互作用诱发的尖端扭转型室速。
Ann Pharmacother. 1999 Jan;33(1):22-6. doi: 10.1345/aph.18107.
7
QT prolongation and Torsades de Pointes associated with clarithromycin.
Am J Med. 1998 Apr;104(4):395-6. doi: 10.1016/s0002-9343(98)00059-x.
8
Moxifloxacin and torsade de pointes.莫西沙星与尖端扭转型室性心动过速
Ann Pharmacother. 2007 Feb;41(2):336-40. doi: 10.1345/aph.1H474. Epub 2007 Feb 6.
9
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.尽管大环内酯类抗生素导致的QT间期延长相似,但它们的促心律失常潜力却不同:快速复极3期可预防早期后除极和尖端扭转型室速。
J Pharmacol Exp Ther. 2002 Oct;303(1):218-25. doi: 10.1124/jpet.102.037911.
10
Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.阿奇霉素在无其他已知诱发因素的情况下导致QT间期延长和尖端扭转型室性心动过速。
J Interv Card Electrophysiol. 2007 Apr;18(3):243-6. doi: 10.1007/s10840-007-9124-y. Epub 2007 Jun 2.

引用本文的文献

1
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.大环内酯类抗生素与老年人室性心律失常风险
CMAJ. 2016 Apr 19;188(7):E120-E129. doi: 10.1503/cmaj.150901. Epub 2016 Feb 22.
2
Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.克拉霉素、QTc间期延长与尖端扭转型室速:对病例报告进行研究的必要性
Ther Adv Infect Dis. 2013 Aug;1(4):121-38. doi: 10.1177/2049936113497203.
3
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study.克拉霉素和罗红霉素的使用与心脏性死亡风险:队列研究

本文引用的文献

1
Low penetrance in the long-QT syndrome: clinical impact.长QT综合征的低外显率:临床影响
Circulation. 1999 Feb 2;99(4):529-33. doi: 10.1161/01.cir.99.4.529.
2
Torsades de pointes induced by erythromycin.
Chest. 1994 Feb;105(2):368-72. doi: 10.1378/chest.105.2.368.
3
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.女性作为与心血管药物相关的尖端扭转型室速的一个危险因素。
JAMA. 1993 Dec 1;270(21):2590-7. doi: 10.1001/jama.270.21.2590.
BMJ. 2014 Aug 19;349:g4930. doi: 10.1136/bmj.g4930.
4
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.14个欧洲国家中接触具有导致QT间期延长风险的抗菌药物情况:8年期间的趋势
Br J Clin Pharmacol. 2009 Jan;67(1):88-98. doi: 10.1111/j.1365-2125.2008.03319.x. Epub 2008 Nov 17.
4
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.胺碘酮相关的致心律失常作用。特别提及尖端扭转型室性心动过速的综述。
Ann Intern Med. 1994 Oct 1;121(7):529-35. doi: 10.7326/0003-4819-121-7-199410010-00009.
5
Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes.完全性房室传导阻滞患者中缓慢性心律失常诱发的异常QT间期延长伴尖端扭转型室性心动过速。
Am J Cardiol. 1992 Mar 1;69(6):628-33. doi: 10.1016/0002-9149(92)90154-q.